Patents by Inventor Patrick L. McGeer

Patrick L. McGeer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peripheral benzodiazepine receptor ligands as antiinflammatory agents
    Patent number: 5776946
    Abstract: Compounds which bind with high affinity to peripheral benzodiazepine receptors are useful as antiinflammatory agents. Such compounds include isoquinoline and benzodiazepine derivatives, such as PK 11195. A method of treating an inflammatory condition in a mammal with such compounds is provided. Pharmaceutical compositions comprising such compounds are provided. A method is provided for identifying compounds that are therapeutically effective for treating inflammatory conditions.
    Type: Grant
    Filed: August 28, 1995
    Date of Patent: July 7, 1998
    Inventors: Patrick L. McGeer, J. Douglas Waterfield, Edith G. McGeer
  • Dapsone and promin for the treatment of dementia
    Patent number: 5532219
    Abstract: This invention pertains to the novel use of 4,4'-diaminodiphenylsulfone and its didextrose sulfonate derivative and other closely related sulfones in the prevention and treatment of dementia (Alzheimer's disease). A method of preventing and treating dementia in a human being suffering from dementia which comprises administering to the human being a therapeutic amount of a substance selected from the group consisting of 4,4'-diaminodiphenylsulfone, its didextrose sulfonate derivative, and sulfoxone, sulfetrone and thiazolsulfone, and therapeutically acceptable salts thereof.
    Type: Grant
    Filed: April 5, 1993
    Date of Patent: July 2, 1996
    Assignee: The University of British Columbia
    Inventors: Patrick L. McGeer, Nobua Harada, Horoshi Kimura, Edith G. McGeer, Michael Schulzer
  • Anti-rheumatoid arthritic drugs in the treatment of dementia
    Patent number: 5192753
    Abstract: This invention pertains to the novel use of anti-rheumatoid arthritic drugs in the treatment of dementia. A method of treating dementia in human beings which comprises administering to the human being a therapeutic amount of a non-steroidal anti-inflammatory drug (NSAID) which has the ability to inhibit prostaglandin synthesis in the human being.
    Type: Grant
    Filed: April 23, 1991
    Date of Patent: March 9, 1993
    Inventors: Patrick L. McGeer, Joseph Rogers, John Sibley, Edith McGeer